Omega Protein Co (NYSE:OME) Rating Restated

New York: In a research note released on 2 August, Pivotal Research reconfirmed their Buy rating on shares of Omega Protein Co (NYSE:OME). They currently have a $30.00 target price per share on the firm. Pivotal Research’s target means a potential upside of 32.28 % from the company’s close price.

NYSE:OME is currently trading 0.00% lower at $22.68 as of 01:49 New York time. Omega Protein Co’s stock is up 29.53% in the past 200 days. It has outperformed the Standard & Poor’s 500 index, which has increased 8.86% in the same time.

Out of 3 brokers covering Omega Protein Co, 2 rate it a Buy, 2 indicate a Hold while 0 suggest a Sell. The highest target is $24 and the lowest is $18 according to Thomson/First Call. The 12-month mean target is $21.67, which means downside potential of 4.45% over the current price.

NYSE:OME Price Chart & Trend

The stock price of Omega Protein Co gained 29.53% over the last 200 days, and is in mighty up trend. In the last 50 and 100 days, Omega Protein Co is up 24.21% and up 3.47%, respectively. Our stocks momentum model is shown on the price chart below.

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

Institutional Ownership

Wynnefield Capital Inc had the largest stake with ownership of 1.38 million shares as of Q2 2015 for 7.32% of the stocks portfolio. Tinicum Inc is another very bullish investment manager who is possessing 610,800 shares of Omega Protein Co or 4.19% of their stocks portfolio. Further, Bruce & Co. Inc. have 1.21% of their stocks portfolio invested in the company for 341,000 shares. The New York-based fund Gerstein Fisher disclosed it had bought a stake worth about 0.79% of the investment manager’s stock portfolio in Omega Protein Co. The Connecticut-based fund Thomson Horstmann & Bryant Inc is also positive about the stock, possessing 168,066 shares or 0.6% of their stocks portfolio.

Omega Protein Co (NYSE:OME) Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (Omega Protein) and Omega Shipyard, Inc. (Omega Shipyard).

Omega Protein Co (NYSE:OME) closed at $22.68 yesterday. A total of shares of the company’s stock traded hands. This is down from average of 146,768 shares. Omega Protein Co has a 52 week low of $13.86 and a 52 week high of $25.49. The company has a market cap of $508.28 million and a P/E ratio of 16.58.

Get the latest Omega Protein Co (NYSE:OME) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Analysts at Pivotal Research Maintained their Buy rating for Omega Protein Co (NYSE:OME). The Target Given is $30.00 appeared first on Octafinance.